Denne dosis kunne reduceres til 3 MIE tre gange ugentligt ad to omgange.
IFN alfa-2a was given up to 52 weeks or until disease progression at a recommend starting dose of 9 MIU three times a week, allowing a dose reduction to 3 MIU three times a week in 2 steps.